 | • レポートコード：QAF27605 • 出版社/出版日：QYResearch / 2021年3月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のカペシタビン市場について種類別（500mg、150mg）、用途別（乳がん、結腸直腸がん、胃がん）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・カペシタビン市場の概要 ・世界の主要地域別カペシタビン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のカペシタビン市場規模2016-2021：種類別（500mg、150mg） ・世界のカペシタビン市場予測2012-2027：種類別（500mg、150mg） ・世界のカペシタビン市場規模2016-2021：用途別（乳がん、結腸直腸がん、胃がん） ・世界のカペシタビン市場予測2012-2027：用途別（乳がん、結腸直腸がん、胃がん） ・カペシタビンのアメリカ市場規模と予測2016-2021 ・カペシタビンのヨーロッパ市場規模と予測2016-2021 ・カペシタビンの中国市場規模と予測2016-2021 ・カペシタビンの日本市場規模と予測2016-2021 ・カペシタビンの東南アジア市場規模と予測2016-2021 ・カペシタビンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Teva、Mylan、Hikma、Hengrui Medicine、Cipla、Reliance Group、Hetero） ・カペシタビンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・カペシタビンの市場動向・機会・課題 ・調査の結論 |
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. The proportion of breast cancer with Handle in 2016 is about 40%, and the proportion of colorectal cancer in 2016 is about 31.94%.
Market Analysis and Insights: Global Capecitabine Market
The global Capecitabine market was valued at US$ 1034.3 in 2020 and will reach US$ 1009.7 million by the end of 2027, growing at a CAGR of -0.4% during 2022-2027.
Global Capecitabine Scope and Market Size
The global Capecitabine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Capecitabine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
500 mg
150 mg
Segment by Application
Breast Cancer
Colorectal Cancer
Stomach Cancer
The Capecitabine market is analysed and market size information is provided by regions (countries). Segment by Application, the Capecitabine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
1 Capecitabine Market Overview
1.1 Capecitabine Product Scope
1.2 Capecitabine Segment by Type
1.2.1 Global Capecitabine Sales by Type (2016 & 2021 & 2027)
1.2.2 500 mg
1.2.3 150 mg
1.3 Capecitabine Segment by Application
1.3.1 Global Capecitabine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Stomach Cancer
1.4 Capecitabine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Capecitabine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Capecitabine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Capecitabine Price Trends (2016-2027)
2 Capecitabine Estimates and Forecasts by Region
2.1 Global Capecitabine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Capecitabine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Capecitabine Sales Market Share by Region (2016-2021)
2.2.2 Global Capecitabine Revenue Market Share by Region (2016-2021)
2.3 Global Capecitabine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Capecitabine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Capecitabine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Capecitabine Estimates and Projections (2016-2027)
2.4.2 Europe Capecitabine Estimates and Projections (2016-2027)
2.4.3 China Capecitabine Estimates and Projections (2016-2027)
2.4.4 Japan Capecitabine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Capecitabine Estimates and Projections (2016-2027)
2.4.6 India Capecitabine Estimates and Projections (2016-2027)
3 Global Capecitabine Competition Landscape by Players
3.1 Global Top Capecitabine Players by Sales (2016-2021)
3.2 Global Top Capecitabine Players by Revenue (2016-2021)
3.3 Global Capecitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Capecitabine as of 2020)
3.4 Global Capecitabine Average Price by Company (2016-2021)
3.5 Manufacturers Capecitabine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Capecitabine Market Size by Type
4.1 Global Capecitabine Historic Market Review by Type (2016-2021)
4.1.1 Global Capecitabine Sales Market Share by Type (2016-2021)
4.1.2 Global Capecitabine Revenue Market Share by Type (2016-2021)
4.1.3 Global Capecitabine Price by Type (2016-2021)
4.2 Global Capecitabine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Capecitabine Sales Forecast by Type (2022-2027)
4.2.2 Global Capecitabine Revenue Forecast by Type (2022-2027)
4.2.3 Global Capecitabine Price Forecast by Type (2022-2027)
5 Global Capecitabine Market Size by Application
5.1 Global Capecitabine Historic Market Review by Application (2016-2021)
5.1.1 Global Capecitabine Sales Market Share by Application (2016-2021)
5.1.2 Global Capecitabine Revenue Market Share by Application (2016-2021)
5.1.3 Global Capecitabine Price by Application (2016-2021)
5.2 Global Capecitabine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Capecitabine Sales Forecast by Application (2022-2027)
5.2.2 Global Capecitabine Revenue Forecast by Application (2022-2027)
5.2.3 Global Capecitabine Price Forecast by Application (2022-2027)
6 North America Capecitabine Market Facts & Figures
6.1 North America Capecitabine Sales by Company
6.1.1 North America Capecitabine Sales by Company (2016-2021)
6.1.2 North America Capecitabine Revenue by Company (2016-2021)
6.2 North America Capecitabine Sales Breakdown by Type
6.2.1 North America Capecitabine Sales Breakdown by Type (2016-2021)
6.2.2 North America Capecitabine Sales Breakdown by Type (2022-2027)
6.3 North America Capecitabine Sales Breakdown by Application
6.3.1 North America Capecitabine Sales Breakdown by Application (2016-2021)
6.3.2 North America Capecitabine Sales Breakdown by Application (2022-2027)
7 Europe Capecitabine Market Facts & Figures
7.1 Europe Capecitabine Sales by Company
7.1.1 Europe Capecitabine Sales by Company (2016-2021)
7.1.2 Europe Capecitabine Revenue by Company (2016-2021)
7.2 Europe Capecitabine Sales Breakdown by Type
7.2.1 Europe Capecitabine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Capecitabine Sales Breakdown by Type (2022-2027)
7.3 Europe Capecitabine Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Capecitabine Market Facts & Figures
8.1 China Capecitabine Sales by Company
8.1.1 China Capecitabine Sales by Company (2016-2021)
8.1.2 China Capecitabine Revenue by Company (2016-2021)
8.2 China Capecitabine Sales Breakdown by Type
8.2.1 China Capecitabine Sales Breakdown by Type (2016-2021)
8.2.2 China Capecitabine Sales Breakdown by Type (2022-2027)
8.3 China Capecitabine Sales Breakdown by Application
8.3.1 China 247 Sales Breakdown by Application (2016-2021)
8.3.2 China 247 Sales Breakdown by Application (2022-2027)
9 Japan Capecitabine Market Facts & Figures
9.1 Japan Capecitabine Sales by Company
9.1.1 Japan Capecitabine Sales by Company (2016-2021)
9.1.2 Japan Capecitabine Revenue by Company (2016-2021)
9.2 Japan Capecitabine Sales Breakdown by Type
9.2.1 Japan Capecitabine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Capecitabine Sales Breakdown by Type (2022-2027)
9.3 Japan Capecitabine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Capecitabine Market Facts & Figures
10.1 Southeast Asia Capecitabine Sales by Company
10.1.1 Southeast Asia Capecitabine Sales by Company (2016-2021)
10.1.2 Southeast Asia Capecitabine Revenue by Company (2016-2021)
10.2 Southeast Asia Capecitabine Sales Breakdown by Type
10.2.1 Southeast Asia Capecitabine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Capecitabine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Capecitabine Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Capecitabine Market Facts & Figures
11.1 India Capecitabine Sales by Company
11.1.1 India Capecitabine Sales by Company (2016-2021)
11.1.2 India Capecitabine Revenue by Company (2016-2021)
11.2 India Capecitabine Sales Breakdown by Type
11.2.1 India Capecitabine Sales Breakdown by Type (2016-2021)
11.2.2 India Capecitabine Sales Breakdown by Type (2022-2027)
11.3 India Capecitabine Sales Breakdown by Application
11.3.1 India Capecitabine Sales Breakdown by Application (2016-2021)
11.3.2 India Capecitabine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Capecitabine Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Capecitabine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Capecitabine Products Offered
12.1.5 Roche Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Capecitabine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Capecitabine Products Offered
12.2.5 Teva Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Business Overview
12.3.3 Mylan Capecitabine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Capecitabine Products Offered
12.3.5 Mylan Recent Development
12.4 Hikma
12.4.1 Hikma Corporation Information
12.4.2 Hikma Business Overview
12.4.3 Hikma Capecitabine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Hikma Capecitabine Products Offered
12.4.5 Hikma Recent Development
12.5 Hengrui Medicine
12.5.1 Hengrui Medicine Corporation Information
12.5.2 Hengrui Medicine Business Overview
12.5.3 Hengrui Medicine Capecitabine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hengrui Medicine Capecitabine Products Offered
12.5.5 Hengrui Medicine Recent Development
12.6 Cipla
12.6.1 Cipla Corporation Information
12.6.2 Cipla Business Overview
12.6.3 Cipla Capecitabine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cipla Capecitabine Products Offered
12.6.5 Cipla Recent Development
12.7 Reliance Group
12.7.1 Reliance Group Corporation Information
12.7.2 Reliance Group Business Overview
12.7.3 Reliance Group Capecitabine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Reliance Group Capecitabine Products Offered
12.7.5 Reliance Group Recent Development
12.8 Hetero
12.8.1 Hetero Corporation Information
12.8.2 Hetero Business Overview
12.8.3 Hetero Capecitabine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hetero Capecitabine Products Offered
12.8.5 Hetero Recent Development
13 Capecitabine Manufacturing Cost Analysis
13.1 Capecitabine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Capecitabine
13.4 Capecitabine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Capecitabine Distributors List
14.3 Capecitabine Customers
15 Market Dynamics
15.1 Capecitabine Market Trends
15.2 Capecitabine Drivers
15.3 Capecitabine Market Challenges
15.4 Capecitabine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Capecitabine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Capecitabine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Capecitabine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Capecitabine Sales (Kg) by Region (2016-2021)
Table 5. Global Capecitabine Sales Market Share by Region (2016-2021)
Table 6. Global Capecitabine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Capecitabine Revenue Share by Region (2016-2021)
Table 8. Global Capecitabine Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Capecitabine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Capecitabine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Capecitabine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Capecitabine Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Capecitabine Sales Share by Company (2016-2021)
Table 14. Global Capecitabine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Capecitabine Revenue Share by Company (2016-2021)
Table 16. Global Capecitabine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Capecitabine as of 2020)
Table 17. Global Capecitabine Average Price (USD/g) of Key Company (2016-2021)
Table 18. Manufacturers Capecitabine Manufacturing Sites and Area Served
Table 19. Manufacturers Capecitabine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Capecitabine Sales (Kg) by Type (2016-2021)
Table 22. Global Capecitabine Sales Share by Type (2016-2021)
Table 23. Global Capecitabine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Capecitabine Price (USD/g) by Type (2016-2021)
Table 25. Global Capecitabine Sales Share by Type (2022-2027)
Table 26. Global Capecitabine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Capecitabine Revenue Share by Type (2022-2027)
Table 28. Global Capecitabine Price (USD/g) by Type (2022-2027)
Table 29. Global Capecitabine Sales (Kg) by Application (2016-2021)
Table 30. Global Capecitabine Sales Share by Application (2016-2021)
Table 31. Global Capecitabine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Capecitabine Price (USD/g) by Application (2016-2021)
Table 33. Global Capecitabine Sales (Kg) by Application (2022-2027)
Table 34. Global Capecitabine Sales Share by Application (2022-2027)
Table 35. Global Capecitabine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Capecitabine Revenue Share by Application (2022-2027)
Table 37. Global Capecitabine Price (USD/g) by Application (2022-2027)
Table 38. North America Capecitabine Sales (Kg) by Company (2016-2021)
Table 39. North America Capecitabine Sales Market Share by Company (2016-2021)
Table 40. North America Capecitabine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Capecitabine Revenue Market Share by Company (2016-2021)
Table 42. North America Capecitabine Sales by Type (2016-2021) & (Kg)
Table 43. North America Capecitabine Sales Market Share by Type (2016-2021)
Table 44. North America Capecitabine Sales by Type (2022-2027) & (Kg)
Table 45. North America Capecitabine Sales Market Share by Type (2022-2027)
Table 46. North America Capecitabine Sales by Application (2016-2021) & (Kg)
Table 47. North America Capecitabine Sales Market Share by Application (2016-2021)
Table 48. North America Capecitabine Sales by Application (2022-2027) & (Kg)
Table 49. North America Capecitabine Sales Market Share by Application (2022-2027)
Table 50. Europe Capecitabine Sales (Kg) by Company (2016-2021)
Table 51. Europe Capecitabine Sales Market Share by Company (2016-2021)
Table 52. Europe Capecitabine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Capecitabine Revenue Market Share by Company (2016-2021)
Table 54. Europe Capecitabine Sales by Type (2016-2021) & (Kg)
Table 55. Europe Capecitabine Sales Market Share by Type (2016-2021)
Table 56. Europe Capecitabine Sales by Type (2022-2027) & (Kg)
Table 57. Europe Capecitabine Sales Market Share by Type (2022-2027)
Table 58. Europe Capecitabine Sales by Application (2016-2021) & (Kg)
Table 59. Europe Capecitabine Sales Market Share by Application (2016-2021)
Table 60. Europe Capecitabine Sales by Application (2022-2027) & (Kg)
Table 61. Europe Capecitabine Sales Market Share by Application (2022-2027)
Table 62. China Capecitabine Sales (Kg) by Company (2016-2021)
Table 63. China Capecitabine Sales Market Share by Company (2016-2021)
Table 64. China Capecitabine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Capecitabine Revenue Market Share by Company (2016-2021)
Table 66. China Capecitabine Sales by Type (2016-2021) & (Kg)
Table 67. China Capecitabine Sales Market Share by Type (2016-2021)
Table 68. China Capecitabine Sales by Type (2022-2027) & (Kg)
Table 69. China Capecitabine Sales Market Share by Type (2022-2027)
Table 70. China Capecitabine Sales by Application (2016-2021) & (Kg)
Table 71. China Capecitabine Sales Market Share by Application (2016-2021)
Table 72. China Capecitabine Sales by Application (2022-2027) & (Kg)
Table 73. China Capecitabine Sales Market Share by Application (2022-2027)
Table 74. Japan Capecitabine Sales (Kg) by Company (2016-2021)
Table 75. Japan Capecitabine Sales Market Share by Company (2016-2021)
Table 76. Japan Capecitabine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Capecitabine Revenue Market Share by Company (2016-2021)
Table 78. Japan Capecitabine Sales by Type (2016-2021) & (Kg)
Table 79. Japan Capecitabine Sales Market Share by Type (2016-2021)
Table 80. Japan Capecitabine Sales by Type (2022-2027) & (Kg)
Table 81. Japan Capecitabine Sales Market Share by Type (2022-2027)
Table 82. Japan Capecitabine Sales by Application (2016-2021) & (Kg)
Table 83. Japan Capecitabine Sales Market Share by Application (2016-2021)
Table 84. Japan Capecitabine Sales by Application (2022-2027) & (Kg)
Table 85. Japan Capecitabine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Capecitabine Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Capecitabine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Capecitabine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Capecitabine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Capecitabine Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Capecitabine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Capecitabine Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Capecitabine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Capecitabine Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Capecitabine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Capecitabine Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Capecitabine Sales Market Share by Application (2022-2027)
Table 98. India Capecitabine Sales (Kg) by Company (2016-2021)
Table 99. India Capecitabine Sales Market Share by Company (2016-2021)
Table 100. India Capecitabine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Capecitabine Revenue Market Share by Company (2016-2021)
Table 102. India Capecitabine Sales by Type (2016-2021) & (Kg)
Table 103. India Capecitabine Sales Market Share by Type (2016-2021)
Table 104. India Capecitabine Sales by Type (2022-2027) & (Kg)
Table 105. India Capecitabine Sales Market Share by Type (2022-2027)
Table 106. India Capecitabine Sales by Application (2016-2021) & (Kg)
Table 107. India Capecitabine Sales Market Share by Application (2016-2021)
Table 108. India Capecitabine Sales by Application (2022-2027) & (Kg)
Table 109. India Capecitabine Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 113. Roche Capecitabine Product
Table 114. Roche Recent Development
Table 115. Teva Corporation Information
Table 116. Teva Description and Business Overview
Table 117. Teva Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 118. Teva Capecitabine Product
Table 119. Teva Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 123. Mylan Capecitabine Product
Table 124. Mylan Recent Development
Table 125. Hikma Corporation Information
Table 126. Hikma Description and Business Overview
Table 127. Hikma Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 128. Hikma Capecitabine Product
Table 129. Hikma Recent Development
Table 130. Hengrui Medicine Corporation Information
Table 131. Hengrui Medicine Description and Business Overview
Table 132. Hengrui Medicine Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 133. Hengrui Medicine Capecitabine Product
Table 134. Hengrui Medicine Recent Development
Table 135. Cipla Corporation Information
Table 136. Cipla Description and Business Overview
Table 137. Cipla Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 138. Cipla Capecitabine Product
Table 139. Cipla Recent Development
Table 140. Reliance Group Corporation Information
Table 141. Reliance Group Description and Business Overview
Table 142. Reliance Group Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 143. Reliance Group Capecitabine Product
Table 144. Reliance Group Recent Development
Table 145. Hetero Corporation Information
Table 146. Hetero Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 147. Hetero Description and Business Overview
Table 148. Hetero Capecitabine Product
Table 149. Hetero Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Capecitabine Distributors List
Table 153. Capecitabine Customers List
Table 154. Capecitabine Market Trends
Table 155. Capecitabine Market Drivers
Table 156. Capecitabine Market Challenges
Table 157. Capecitabine Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Capecitabine Product Picture
Figure 2. Global Capecitabine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Capecitabine Sales Market Share by Application in 2021 & 2027
Figure 6. Breast Cancer Examples
Figure 7. Colorectal Cancer Examples
Figure 8. Stomach Cancer Examples
Figure 9. Global Capecitabine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Capecitabine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Capecitabine Sales (Kg) Growth Rate (2016-2027)
Figure 12. Global Capecitabine Price Trends Growth Rate (2016-2027) (USD/g)
Figure 13. Global Capecitabine Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Capecitabine Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Capecitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Capecitabine Sales (Kg) Growth Rate (2016-2027)
Figure 17. Europe Capecitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Capecitabine Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Capecitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Capecitabine Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Capecitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Capecitabine Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Capecitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Capecitabine Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Capecitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Capecitabine Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Capecitabine Players Market Share by Revenue in Capecitabine: 2016 & 2020
Figure 28. Capecitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Capecitabine Revenue Share by Type (2016-2021)
Figure 30. Global Capecitabine Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Capecitabine Revenue Share by Application (2016-2021)
Figure 32. Global Capecitabine Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Capecitabine Sales Market Share by Type in 2020
Figure 34. North America Capecitabine Sales Market Share by Application in 2020
Figure 35. Europe Capecitabine Sales Market Share by Type in 2020
Figure 36. Europe Capecitabine Sales Market Share by Application in 2020
Figure 37. China Capecitabine Sales Market Share by Type in 2020
Figure 38. China Capecitabine Sales Market Share by Application in 2020
Figure 39. Japan Capecitabine Sales Market Share by Type in 2020
Figure 40. Japan Capecitabine Sales Market Share by Application in 2020
Figure 41. Southeast Asia Capecitabine Sales Market Share by Type in 2020
Figure 42. Southeast Asia Capecitabine Sales Market Share by Application in 2020
Figure 43. India Capecitabine Sales Market Share by Type in 2020
Figure 44. India Capecitabine Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Capecitabine
Figure 47. Manufacturing Process Analysis of Capecitabine
Figure 48. Capecitabine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
カペシタビンフマル酸塩のグローバル市場調査 2019年 The global Capecitabine Fumarate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Capecitabine Fumarate volume and value at global level, regional level and company level. From a global perspective, …- 世界の胆管がん治療薬市場規模・現状・予測（2021年-2027年） Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unkno…
- 世界の遺伝性大腸がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing hereditary colorectal cancer Market Analysis and Insights: Global Molecular Diagnosis of Hereditary Colorectal Cancer Market The global Molecular Diagnosis of Hereditary Colorectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の胃がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing stomach cancer Market Analysis and Insights: Global Stomach Cancer Molecular Diagnostics Market The global Stomach Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
- 乳がん検診のグローバル市場2021 Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis. A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnet…